BioWorld Asia

Feb. 6, 2002

EU Biotech Industry Welcomes European Commission Strategy

BRUSSELS, Belgium The European biotechnology industry has given an enthusiastic welcome to the European Union’s latest attempt to bring order to the often-chaotic regulatory environment for biotechnology. (BioWorld International) Read More

France Biotech Wants Initiatives To Assist Industry Across EU

Gene Comparisons Suggest New Targets For Down’s Syndrome

Cytos Raises CHF45M In Third Round Following Productive Year

German Officials Compromise In Embryonic Stem Cell Debate

BioImage Raises EUR15.2M For Protein Translocation Work

Adaptive Screening Emerges As Player In Nanotechnology

BioVisioN Raises EUR15M To Progress Programs In Peptides

Cerep Extends Drug Discovery Deal With Sanofi-Synth labo

Hybrigenics, Mindsense Align To Advance Work In Depression

Proteome Gains Patent, Pushes Forward In Prion Diagnostics

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for March 11, 2026.

Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

Cas and effect: Merck’s phase III ripples HIF-2α space

BioWorld

Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...

Tanycytes in green capturing tau protein in red.

Brain’s hidden tau-clearing pathway uncovered

BioWorld Science

Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 10, 2026

MSD synthesizes α-synuclein PET agents

BioWorld Science

Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...